These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 3160784

  • 1. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2).
    Rocklin RE, Thistle L, Audera C.
    J Immunol; 1985 Sep; 135(3):2033-9. PubMed ID: 3160784
    [Abstract] [Full Text] [Related]

  • 2. Separation of a population of human T lymphocytes that bind prostaglandin E2 and exert a suppressor activity.
    Fischer A, Le Deist F, Durandy A, Griscelli C.
    J Immunol; 1985 Feb; 134(2):815-9. PubMed ID: 2856929
    [Abstract] [Full Text] [Related]

  • 3. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes.
    Chouaib S, Chatenoud L, Klatzmann D, Fradelizi D.
    J Immunol; 1984 Apr; 132(4):1851-7. PubMed ID: 6230395
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
    Makoul GT, Robinson DR, Bhalla AK, Glimcher LH.
    J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human T lymphocyte E rosette formation by neutrophils and hydrogen peroxide. Differential sensitivity between helper and suppressor T lymphocytes.
    Staite ND, Messner RP, Zoschke DC.
    J Immunol; 1987 Oct 01; 139(7):2424-30. PubMed ID: 2958549
    [Abstract] [Full Text] [Related]

  • 6. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells.
    Rola-Pleszczynski M, Pouliot C, Turcotte S, Pignol B, Braquet P, Bouvrette L.
    J Immunol; 1988 May 15; 140(10):3547-52. PubMed ID: 2834440
    [Abstract] [Full Text] [Related]

  • 7. Regulation of human B cell proliferation by prostaglandin E2.
    Thompson PA, Jelinek DF, Lipsky PE.
    J Immunol; 1984 Nov 15; 133(5):2446-53. PubMed ID: 6332851
    [Abstract] [Full Text] [Related]

  • 8. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
    McLeish KR, Stelzer GT, Eades DS, Cohen R, Wallace JH.
    J Lab Clin Med; 1985 Nov 15; 106(5):517-23. PubMed ID: 2932513
    [Abstract] [Full Text] [Related]

  • 9. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.
    Koster FT, Williams JC, Goodwin JS.
    J Immunol; 1985 Aug 15; 135(2):1067-72. PubMed ID: 2409135
    [Abstract] [Full Text] [Related]

  • 10. Modulation of the immunoreactivity of a T-lymphocyte subpopulation by neutrophil-released prostaglandin.
    Niwa Y, Sakane T, Fukuda Y, Miyachi Y, Kanoh T.
    J Clin Lab Immunol; 1985 May 15; 17(1):37-44. PubMed ID: 2931529
    [Abstract] [Full Text] [Related]

  • 11. Strong prostaglandin associated suppression of the proliferation of human maternal lymphocytes by neonatal lymphocytes linked to T versus T cell interactions and differential PGE2 sensitivity.
    Papadogiannakis N, Johnsen SA, Olding LB.
    Clin Exp Immunol; 1985 Jul 15; 61(1):125-34. PubMed ID: 2931220
    [Abstract] [Full Text] [Related]

  • 12. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity.
    Fischer A, Durandy A, Griscelli C.
    J Immunol; 1981 Apr 15; 126(4):1452-5. PubMed ID: 6451647
    [Abstract] [Full Text] [Related]

  • 13. Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release.
    Nishi S, Seino Y, Seino S, Tsuda K, Takemura J, Shimizu T, Hayashi O, Imura H.
    Horm Metab Res; 1984 Dec 15; 16 Suppl 1():114-8. PubMed ID: 6152434
    [Abstract] [Full Text] [Related]

  • 14. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
    Watanabe T, Satoh H, Togoh M, Taniguchi S, Hashimoto Y, Kurokawa K.
    J Cell Physiol; 1996 Nov 15; 169(2):401-9. PubMed ID: 8908208
    [Abstract] [Full Text] [Related]

  • 15. Decreased natural killer cell activity in atopic eczema.
    Hall TJ, Rycroft R, Brostoff J.
    Immunology; 1985 Oct 15; 56(2):337-44. PubMed ID: 3876984
    [Abstract] [Full Text] [Related]

  • 16. Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin.
    Brown SL, Van Epps DE.
    J Immunol; 1985 May 15; 134(5):3384-90. PubMed ID: 3156934
    [Abstract] [Full Text] [Related]

  • 17. Regulation by prostaglandin E2 of interleukin release by T lymphocytes in mucosa.
    Barrera S, Lai J, Fiocchi C, Roche JK.
    J Cell Physiol; 1996 Jan 15; 166(1):130-7. PubMed ID: 8557762
    [Abstract] [Full Text] [Related]

  • 18. Reduced prostaglandin E2 (PGE2) receptors on atopic T lymphocytes.
    Rocklin RE, Thistle L.
    Cell Immunol; 1986 Apr 15; 99(1):294-9. PubMed ID: 2875801
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK, Barnes PJ, Giembycz MA.
    Br J Pharmacol; 1997 Sep 15; 122(1):149-57. PubMed ID: 9298541
    [Abstract] [Full Text] [Related]

  • 20. Divergent T gamma cell functions in antigen-induced blastogenesis: facilitory interactions with Tnon gamma cells and participation in monocyte- and prostaglandin-mediated suppression.
    Kleinhenz ME, Ellner JJ.
    J Lab Clin Med; 1983 Nov 15; 102(5):751-61. PubMed ID: 6226756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.